Geode Capital Management, LLC Alx Oncology Holdings Inc Transaction History

Geode Capital Management, LLC

$1.12 Trillion
Q2 2024

A detailed history of Geode Capital Management, LLC transactions in Alx Oncology Holdings Inc stock. As of the latest transaction made, Geode Capital Management, LLC holds 700,406 shares of ALXO stock, worth $1.38 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

700,406

Previous 604,714 15.82%

Holding current value

$1.38 Million

Previous $6.74 Million 37.36%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$5.84 - $17.56 $558,841 - $1.68 Million	95,692 Added 15.82%	700,406 $4.22 Million
Q1 2024 May 13, 2024	BUY	$10.95 - $16.79 $215,496 - $330,427	19,680 Added 3.36%	604,714 $6.74 Million
Q4 2023 Feb 13, 2024	BUY	$4.81 - $15.38 $682,861 - $2.18 Million	141,967 Added 32.04%	585,034 $8.71 Million
Q3 2023 Nov 13, 2023	SELL	$4.19 - $7.35 $5,157 - $9,047	-1,231 Reduced 0.28%	443,067 $2.13 Million
Q2 2023 Aug 11, 2023	BUY	$4.37 - $9.56 $101,619 - $222,308	23,254 Added 5.52%	444,298 $3.34 Million
Q1 2023 May 15, 2023	BUY	$4.52 - $11.71 $39,482 - $102,286	8,735 Added 2.12%	421,044 $1.9 Million
Q4 2022 Feb 13, 2023	BUY	$9.51 - $12.95 $180,575 - $245,894	18,988 Added 4.83%	412,309 $4.65 Million
Q3 2022 Nov 14, 2022	BUY	$8.23 - $15.14 $107,985 - $198,651	13,121 Added 3.45%	393,321 $3.76 Million
Q2 2022 Aug 12, 2022	BUY	$5.89 - $19.46 $352,569 - $1.16 Million	59,859 Added 18.69%	380,200 $3.08 Million
Q1 2022 May 13, 2022	SELL	$13.65 - $22.06 $266,243 - $430,280	-19,505 Reduced 5.74%	320,341 $5.41 Million
Q4 2021 Feb 11, 2022	SELL	$21.49 - $74.4 $440,544 - $1.53 Million	-20,500 Reduced 5.69%	339,846 $7.3 Million
Q3 2021 Nov 12, 2021	BUY	$52.51 - $80.91 $4.31 Million - $6.64 Million	82,069 Added 29.49%	360,346 $26.6 Million
Q2 2021 Aug 13, 2021	BUY	$52.2 - $75.23 $326,772 - $470,939	6,260 Added 2.3%	278,277 $15.2 Million
Q1 2021 May 12, 2021	BUY	$62.84 - $87.68 $5.73 Million - $7.99 Million	91,149 Added 50.4%	272,017 $20.1 Million
Q4 2020 Feb 12, 2021	BUY	$34.11 - $112.26 $895,012 - $2.95 Million	26,239 Added 16.97%	180,868 $15.6 Million
Q3 2020 Nov 13, 2020	BUY	$29.36 - $47.1 $4.54 Million - $7.28 Million	154,629 New	154,629 $5.84 Million

Others Institutions Holding ALXO

# of Institutions

122

Shares Held

40.7M

Call Options Held

518K

Put Options Held

142K

View Full List

About ALX ONCOLOGY HOLDINGS INC

Ticker ALXO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,747,100
Market Cap $80.3M
Description
ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...

More about ALXO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Alx Oncology Holdings Inc Transaction History